[Federal Register Volume 89, Number 192 (Thursday, October 3, 2024)]
[Notices]
[Page 80452]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22826]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-32-2024]


Foreign-Trade Zone (FTZ) 22; Authorization of Production 
Activity; AbbVie, Inc.; (Pharmaceutical Products); North Chicago, 
Illinois

    On May 31, 2024, AbbVie, Inc. submitted a notification of proposed 
production activity to the FTZ Board for its facilities within Subzone 
22S, in North Chicago, Illinois.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (89 FR 51495, June 18, 2024). On 
September 30, 2024, the applicant was notified of the FTZ Board's 
decision that no further review of the activity is warranted at this 
time. The production activity described in the notification was 
authorized, subject to the FTZ Act and the FTZ Board's regulations, 
including section 400.14.

    Dated: September 30, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024-22826 Filed 10-2-24; 8:45 am]
BILLING CODE 3510-DS-P